In an attempt to expand its product portfolio that addresses pain therapeutic solutions, Medtronic plc MDT recently launched its OsteoCool radiofrequency (RF) Ablation System in the U.S. market, subsequent to the receipt of the FDA 510(k) approval for the same. The OsteoCool System is designed to treat cancer patients suffering from painful spinal metastasis.  Incidentally, the OsteoCool […]

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone